Trading · Founded 1994 · http://www.devikaproteins.com/ · BSE 531171 · · ISIN INE248C01021
No Notes Added Yet
Business
Dharti Proteins Ltd. operates in the trading sector in India, specializing in the buying and selling of protein-rich commodities or related products. The company's core business model involves procuring goods, potentially from farmers or processors, managing logistics, and then distributing or selling these commodities to other businesses such as food manufacturers, wholesalers, or retailers. It generates revenue by managing supply chains, leveraging market knowledge to buy at competitive prices, and selling at a margin, often involving inventory management and dealing with price fluctuations in the commodity markets.
Revenue Mix
Given its name, Dharti Proteins' primary revenue is likely derived from the trading of various protein-related commodities. Without specific data, potential segments could include:
Trading of Agricultural Commodities: Such as oilseeds (e.g., soybean, groundnut), pulses (e.g., lentils, chickpeas), or grains.
Processed Protein Products: Trading in value-added products like soy meal, protein concentrates, or other protein ingredients for food and feed industries.
Specific contribution percentages for these segments are not publicly available.
Industry
The commodity trading industry in India is generally fragmented, competitive, and often characterized by low-profit margins on high volumes. Companies like Dharti Proteins compete on various factors including the efficiency of their procurement and distribution networks, their ability to gather and act on market intelligence, and the strength of their relationships with both suppliers and customers. Dharti Proteins likely positions itself within a specific niche of the protein commodity market, with its standing against peers depending on its operational scale, geographical reach, and expertise in particular protein types.
MOAT
Pure trading businesses typically have narrow competitive advantages. For Dharti Proteins, potential moats, if present, could stem from:
Strong Supplier & Customer Relationships: Long-standing, trusted relationships can ensure consistent supply and reliable demand channels.
Operational Efficiency: A highly optimized and cost-effective logistics and supply chain network can reduce costs and improve delivery times.
Market Intelligence & Risk Management: Superior ability to forecast market trends, manage inventory, and mitigate commodity price volatility.
Scale (if significant): Large trading volumes can lead to better purchasing power and lower per-unit operational costs.
However, these advantages are often difficult to sustain and are subject to continuous competitive pressure.
Growth Drivers
Key factors that could drive growth for Dharti Proteins Ltd. over the next 3-5 years include:
Rising Protein Demand: Increasing population, urbanization, and rising disposable incomes in India are driving higher per-capita consumption of protein-rich foods.
Diversification of Product Portfolio: Expansion into new protein commodities, derivatives, or related value-added products.
Geographical Expansion: Extending procurement and distribution networks to new regions within India or exploring export opportunities.
Supply Chain Integration & Optimization: Investments in warehousing, logistics, and technology to enhance efficiency and reduce costs across the value chain.
Government Initiatives: Favorable agricultural policies or support for food processing and trading sectors.
Risks
Dharti Proteins Ltd. is exposed to several inherent risks associated with its trading business:
Commodity Price Volatility: Fluctuations in global and domestic prices of protein commodities can significantly impact profitability due to inventory holding periods and contract pricing.
Supply Chain Disruptions: Adverse weather conditions, logistical bottlenecks, transportation strikes, or geopolitical events can disrupt procurement and distribution.
Intense Competition: The fragmented nature of the trading industry leads to constant pressure on margins and the need for operational excellence.
Regulatory & Policy Changes: Changes in agricultural policies, import/export duties, food safety standards, or trade regulations can impact operations and costs.
Inventory & Perishability Risk: Holding large inventories can expose the company to price declines or losses due to spoilage, especially with agricultural commodities.
Credit Risk: Potential for non-payment or delayed payment from customers, impacting cash flow.
Management & Ownership
As is common with many companies in India, Dharti Proteins Ltd. is likely to be promoter-driven, with a significant ownership stake held by the founding family or individuals who also play a key role in the company's management and strategic decision-making. The quality of management would depend on their experience in the protein commodity trading sector, their ability to navigate market cycles and risks, their financial acumen, and adherence to sound corporate governance practices.
Outlook
Dharti Proteins operates in a sector with structural tailwinds from India's growing population and increasing protein consumption. This fundamental demand provides a long-term growth opportunity. However, the trading business itself is inherently challenging, characterized by low margins, intense competition, and significant exposure to commodity price volatility and supply chain risks. The company's future performance will largely depend on its ability to execute an efficient supply chain, maintain strong relationships with its ecosystem, accurately forecast market trends, and effectively mitigate the various risks inherent in commodity trading. The outlook is balanced, acknowledging both the potential for growth in a critical sector and the significant operational and market challenges that must be continually addressed.
| #(Fig in Cr.) | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 |
| Total Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 |
| Total Expenditure | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| Operating Profit | -0 | -0 | -0 | 0 | -0 | -0 | -0 | -0 | -0 | 4 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | 0 | 0 |
| Profit Before Tax | -0 | -0 | -0 | 0 | -0 | -0 | -0 | -0 | -0 | 4 |
| Provision for Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Profit After Tax | -0 | -0 | -0 | 0 | -0 | -0 | -0 | -0 | -0 | 3 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 |
| Profit After Adjustments | -0 | -0 | -0 | 0 | -0 | -0 | -0 | -0 | -0 | 3 |
| Adjusted Earnings Per Share | -0 | -0 | -0 | 0 | -0 | -0 | -0.3 | -9.1 | -2.8 | 67.4 |
| #(Fig in Cr.) | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
| Net Sales | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 3 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 |
| Total Income | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 6 |
| Total Expenditure | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 2 |
| Operating Profit | 0 | 0 | -0 | -1 | -0 | -0 | -0 | 4 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -0 | -0 | -0 | -1 | -0 | -0 | -0 | 4 |
| Provision for Tax | -0 | 0 | -0 | -0 | 0 | 0 | 0 | 1 |
| Profit After Tax | -0 | -0 | -0 | -1 | -0 | -0 | -0 | 3 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | -0 | -0 | -0 | -1 | -0 | -0 | -0 | 3 |
| Adjusted Earnings Per Share | -0 | -0.3 | -0 | -0.7 | -0.1 | -0.2 | -0 | 55.2 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 0% | 0% | 0% | 0% |
| Operating Profit CAGR | 0% | 0% | 0% | 0% |
| PAT CAGR | 0% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | NA% | NA% | NA% | 29% |
| ROE Average | -52% | -20% | -15% | -12% |
| ROCE Average | -0% | -1% | -3% | -2% |
| #(Fig in Cr.) | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 6 | 6 | 6 | 5 | 5 | 0 | 0 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
| Other Non-Current Liabilities | -0 | -0 | -0 | -0 | 0 | 0 | 0 |
| Total Current Liabilities | 3 | 2 | 2 | 2 | 2 | 0 | 5 |
| Total Liabilities | 10 | 9 | 9 | 8 | 8 | 2 | 7 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Other Non-Current Assets | 7 | 7 | 7 | 6 | 6 | 2 | 2 |
| Total Current Assets | 2 | 3 | 2 | 2 | 2 | 0 | 5 |
| Total Assets | 10 | 9 | 9 | 8 | 8 | 2 | 7 |
| #(Fig in Cr.) | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash Flow from Operating Activities | -0 | -0 | -0 | -0 | -0 | -0 | 4 |
| Cash Flow from Investing Activities | -0 | 1 | 0 | 0 | 0 | 0 | -3 |
| Cash Flow from Financing Activities | 0 | -0 | 0 | -0 | -0 | 0 | 0 |
| Net Cash Inflow / Outflow | -0 | 0 | 0 | 0 | -0 | -0 | 1 |
| Closing Cash & Cash Equivalent | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| # | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | -0.03 | -0.31 | -0.03 | -0.7 | -0.07 | -0.19 | -0.01 |
| CEPS(Rs) | -0.03 | -0.31 | -0.03 | -0.7 | -0.07 | -0.18 | -0 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 6.08 | 5.77 | 5.74 | 5.04 | 4.97 | 0.02 | 0.01 |
| Core EBITDA Margin(%) | -3.04 | 8.81 | 0 | 0 | 0 | 0 | 0 |
| EBIT Margin(%) | 4.22 | 13.39 | 0 | 0 | 0 | 0 | 0 |
| Pre Tax Margin(%) | -2.7 | -37.91 | 0 | 0 | 0 | 0 | 0 |
| PAT Margin (%) | -2.69 | -178.24 | 0 | 0 | 0 | 0 | 0 |
| Cash Profit Margin (%) | -2.66 | -178.1 | 0 | 0 | 0 | 0 | 0 |
| ROA(%) | -0.3 | -3.37 | -0.37 | -8.35 | -0.94 | -3.69 | -0.15 |
| ROE(%) | -0.46 | -5.24 | -0.57 | -12.92 | -1.5 | -7.43 | -52.38 |
| ROCE(%) | 0.58 | 0.31 | -0.46 | -10.56 | -1.02 | -0.6 | -0.32 |
| Receivable days | 818.68 | 5046.37 | 0 | 0 | 0 | 0 | 0 |
| Inventory Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Payable days | 588.44 | 4775.09 | 0 | 0 | 0 | 0 | 0 |
| PER(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Price/Book(x) | 0.98 | 0.49 | 0.7 | 1.4 | 1.19 | 0 | 0 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 7.25 | 25.08 | 0 | 0 | 0 | 0 | 0 |
| EV/Core EBITDA(x) | 170.39 | 185.4 | -158.09 | -11.66 | -112.66 | -574.4 | -3805.34 |
| Net Sales Growth(%) | -60.76 | -83.17 | -100 | 0 | 0 | 0 | 0 |
| EBIT Growth(%) | 164.14 | -46.55 | -241.72 | -2022.15 | 90.9 | 61.78 | 74.1 |
| PAT Growth(%) | 94.94 | -1013.39 | 89.39 | -2013.47 | 89.25 | -146.98 | 96.53 |
| EPS Growth(%) | 94.94 | -1013.57 | 89.38 | -2010.29 | 89.25 | -147.02 | 96.54 |
| Debt/Equity(x) | 0.26 | 0.28 | 0.22 | 0.25 | 0.25 | 126.87 | 221.22 |
| Current Ratio(x) | 0.91 | 1.09 | 1.3 | 1.34 | 1.3 | 0.28 | 0.99 |
| Quick Ratio(x) | 0.91 | 1.09 | 1.3 | 1.34 | 1.3 | 0.28 | 0.99 |
| Interest Cover(x) | 0.61 | 0.26 | -25.53 | -1465.97 | -970.1 | -0.15 | -65 |
| Total Debt/Mcap(x) | 0.26 | 0.57 | 0.31 | 0.18 | 0.21 | 0 | 0 |
| # | Mar 2014 | Jun 2014 | Sep 2014 | Dec 2014 | Mar 2015 | Jun 2015 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 2.76 | 2.72 | 2.72 | 2.71 | 2.71 | 2.71 | 1.74 | 85 | 85 | 85 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 97.24 | 97.28 | 97.28 | 97.29 | 97.29 | 97.29 | 98.26 | 15 | 15 | 15 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2014 | Jun 2014 | Sep 2014 | Dec 2014 | Mar 2015 | Jun 2015 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | 0.04 | 0.04 | 0.04 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 1 | 1 | 1 | 1 | 1 | 1 | 1.01 | 0.01 | 0.01 | 0.01 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 0.05 | 0.05 | 0.05 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | — | — | — | — |
| Operating Profit CAGR | — | — | — | — |
| PAT CAGR | — | — | — | — |
| Share Price CAGR | — | — | — | +29% |
| ROE Average | -52% | -20% | -15% | -12% |
| ROCE Average | 0% | -1% | -3% | -2% |
| # | Mar 2014 | Jun 2014 | Sep 2014 | Dec 2014 | Mar 2015 | Jun 2015 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 2.76 | 2.72 | 2.72 | 2.71 | 2.71 | 2.71 | 1.74 | 85 | 85 | 85 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 97.24 | 97.28 | 97.28 | 97.29 | 97.29 | 97.29 | 98.26 | 15 | 15 | 15 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2014 | Jun 2014 | Sep 2014 | Dec 2014 | Mar 2015 | Jun 2015 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | 0.04 | 0.04 | 0.04 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 1 | 1 | 1 | 1 | 1 | 1 | 1.01 | 0.01 | 0.01 | 0.01 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 0.05 | 0.05 | 0.05 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.